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A comparison of the diagnostic value of 19-gauge histology
and 22-gauge cytology needles in bronchoscopy for the
evaluation of endobronchial lesions
Elif YILMAZEL UÇAR1 Mehmet MERAL1, Metin AKGÜN1, Sare ŞİPAL2,
Hasan KAYNAR1, Leyla SAĞLAM1, Ali Metin GÖRGÜNER1

Aim: To prospectively compare the sensitivity of Wang 22-gauge needle aspiration and 19-gauge needle aspiration with
bronchial biopsy and determine whether there was difference between 22-gauge and 19-gauge needle aspirations in the
diagnosis of endobronchial malignancies.
Materials and methods: All patients (63 patients) in the study underwent fiberoptic bronchoscopy that included
22-gauge needle aspiration and 19-gauge needle aspiration. In 50 patients bronchial biopsy was done. The sensitivities
of the individual techniques were compared.
Results: Cancer was diagnosed in 48 patients by 22-gauge needle aspiration and 19-gauge needle aspiration, and in
43 patients by bronchial biopsy. The sensitivity of bronchial biopsy was 0.86. The addition of 22-gauge and 19-gauge
needle aspirations to bronchial biopsy increased the sensitivity to 0.90 and 0.88, respectively, but the difference was not
statistically significant (P = 1.0). The maximal diagnostic yield was obtained with the combination of needle aspirations
and forceps biopsy in the detection of submucosal or peribronchial bronchogenic carcinoma (100%) (P < 0.05).
Conclusion: The combination of forceps biopsy and transbronchial needle aspirations should be used for the highest
rate of bronchoscopic diagnostic yield. However, there was no difference for increasing diagnostic yield in patients with
visible endobronchial lesions between 22-gauge and 19- gauge needles.
Key words: Bronchoscopy, endobronchial lesions, forceps biopsy, transbronchial needle aspiration

Endobronşiyal lezyonların bronkoskopik incelemesinde 19-gauge histoloji
ve 22-gauge sitoloji iğnelerinin tanı değerlerinin karşılaştırılması
Amaç: İleriye dönük olarak yaptığımız bu çalışmada, endobronşiyal malignitelerin tanısında bronşiyal biyopsi ile
birlikte Wang 22-gauge ve 19-gauge iğne aspirasyonlarının duyarlılığı ve 22-gauge ve 19-gauge iğne aspirasyonları
arasında farklılık olup olmadığını karşılaştırmayı amaçladık.
Yöntem ve gereç: Çalışmaya alınan tüm hastalara (63 hasta) fiberoptik bronkoskopiyle 22-gauge ve 19-gauge iğne
aspirasyonları yapıldı. Biyopsi, hastalardan 50’ne uygulandı. Her bir tekniğin duyarlılığı karşılaştırıldı.
Bulgular: Biyopsiyle 43 hastaya, 19-gauge iğne aspirasyonu ve 22-gauge iğne aspirasyonu ile 48 hastaya kanser tanısı
konuldu. Bronşiyal biyopsinin duyarlılığı % 86 idi. Biyopsinin, 22-gauge iğne aspirasyonu ile kombinasyonuyla bu
duyarlılık % 90’a, 19-gauge iğne aspirasyonu ile kombinasyonuyla % 88’e çıktı. Fakat, istatiksel olarak anlamlı farklılık
yoktu (P = 1,0). Submukozal-peribronşiyal bronkojenik karsinomların belirlenmesinde iğne aspirasyonları ve forseps
biyopsinin kombinasyonuyla maksimal tanısal oran elde edildi (% 100) (P < 0,05).
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Sonuç: En yüksek bronkoskopik tanısal oran için forseps biyopsi ve transbronşiyal iğne aspirasyonları birlikte
yapılmalıdır. Endobronşiyal lezyonlarda tanı oranını artırmak için 22-gauge ve 19-gauge iğne aspirasyonları arasında
farklılık gözlenmemiştir.
Anahtar sözcükler: Bronkoskopi, endobronşiyal lezyonlar, forseps biyopsi, transbronşiyal iğne aspirasyonu

Introduction
Fiberoptic bronchoscopy (FOB) is a minimally
invasive procedure commonly used in the diagnosis
and staging of lung cancer (1). It provides highly
valuable information to the physician in determining
the treatment strategies for endobronchial lesions
by facilitating direct observation of the lesions. FOB
also allows biopsy procedures of directly observed
endobronchial lesions and transbronchial fine needle
aspiration (TBFNA) of tumors with indirect findings,
thus facilitating cytopathological evaluations.
Although all the benefits and uses of bronchoscopy
have been well defined, there has been an increasing
tendency to use advanced invasive methods that
are relatively more time consuming, costly, and
presenting higher mortality and morbidity rates
compared to bronchoscopy (1).
However, a well-planned bronchoscopic
evaluation has been reported to provide higher
diagnostic rates in patients suspected for lung cancer
and spare some patients from undergoing advanced
invasive methods and redundant thoracotomy (2-6).
In consensus reports on bronchoscopy to date, the
regular use of biopsy, endobronchial brushing, and
isotonic lavage concomitantly has been advocated
(7,8), and, according to these reports, the diagnostic
accuracy of these 3 procedures has ranged between
71% and 87% based on the results of various studies.
As can be deduced from these results, only 15%-20%
of patients require a second bronchoscopy procedure
or further diagnostic techniques.
Needle aspirations via flexible bronchoscopy (FB)
are also used a sampling method for a variety of
bronchial, peribronchial, or pulmonary lesions (9).
Its ability to establish diagnosis and staging in a single
noninvasive intervention has made transbronchial
needle aspiration (TBNA) the key technique for
the evaluation of patients with suspected lung
cancer (10,11). Wang 19-gauge and 22-gauge fine
needles have been compared in biopsy procedures
of mediastinal lymph nodes (12). However, to best
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of our knowledge, no such comparisons have been
made for endobronchial lesions so far in the English
literature, and therefore data on this subject have
remained limited.
We aimed to determine whether endoscopic fine
needle aspiration (EFNA) would provide additional
benefits to the conventional diagnostic interventions
(forceps biopsy, brushing, or lavage) described above
in suspected lung cancer patients scheduled for
routine bronchoscopy, particularly in endobronchial
lesions directly observed during initial bronchoscopy
and areas associated with indirect tumoral findings
(abnormalities in the mucosal folds such as mucosal
thickening, indistinctness or disappearance, mucosal
paleness, absence of mucosal surface luster, irregular
mucosal surface, increased vascularity, concentric
stenosis of the lumen, external compression, etc.).
The study also aimed to compare the diagnostic and
complication rates of Wang 19-gauge and 22-gauge
needles used in this procedure.
Materials and methods
The study population consisted of patients who
underwent routine bronchoscopy evaluation for
suspected lung cancer for 2 years. The patient and his/
her relatives were informed of the present pathology
and the interventions planned. The method of
application, the requirement for the procedure, the
results, and the potential risks were explained. We
sought and obtained ethics approval from Atatürk
University Local Ethics Committee.
Before bronchoscopy, chest X-ray and
computerized tomography results of the thorax of
the patients were available. All the blood values
and coagulation tests were monitored. In the
bronchoscopic evaluation, endobronchial lesions
were categorized as exophytic mass lesions (EML) and
submucosal/peribronchial lesions (SPL) according
to the characteristics of the lesions. Submucosal
disease was described as bronchial narrowing,
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mucosal thickening, disappearance of mucosal signs,
erythema, increase of placation, and marked vascular
structure. Peribronchial disease was defined as a
secondary narrowing of the lumen against external
compression (13).
All the patients underwent fine needle aspiration
with both Wang 22-gauge cytology and 19-gauge
histology needles followed by routine procedures
(brushing, forceps biopsy, lavage, etc.) depending on
the characteristics of the endobronchial lesion.
To keep the risk of contamination to a minimum,
fine needle aspirations were primarily performed.
Before the needle aspiration, the secretions from
the area where the procedure would be performed
were cleaned. The aspirations were done first using a
22-gauge cytology needle and then by using a 19-gauge
histology needle. Depending on the characteristics of
the lesion, one or more of the penetration methods
(Jabbing, Piggy-back, Hub-Against-the-Wall, or
Cough) (14) was used. In the submucosal lesions,
the penetration was realized at a 45° angle, while in
the other lesions direct insertion was made. After
making sure that the needle was properly inserted, it
was minimally advanced and aspiration was carried
out. For aspiration, a 50-mL injector was used.
After completion of the aspiration, the needles were
withdrawn into their sheaths and removed from the
biopsy channel. The material obtained was fixed on
slides using fixation solution [Ethanol R:11-S;7-16
(BIO-FIX®)] and sent for pathological evaluation.
All the findings were evaluated by an experienced
pathologist. The pathology results were classified as
positive or negative for malignancy.
Statistical analysis
Statistical analyses were performed using SPSS
11.0. Comparisons of the results obtained with the
2 different needles and their comparisons with the
biopsy results were done with McNemar’s test. The
compatibility of the needles with each other and
with the biopsy results was evaluated using the
Kappa method. P < 0.05 was considered statistically
significant.
Results
The study included 63 patients. The mean age
of the patients was 60 ± 12 years (range: 22-81

years), and 55 (87%) were male and 8 (13%) were
female. Of the patients, 60 were diagnosed with
malignancy by bronchoscopic methods and 3 by
Tru-Cut biopsy. Table 1 summarizes the radiological
and bronchoscopic characteristics of the lesions.
The lesions were mostly located in the right lung
(57%); 62% were exophytic masses and 38% were
submucosal/peribronchial in nature.

Table 1. Radiographic and bronchoscopic characteristics of the
lesions.
Characteristics

n (%)

Radiographic location of the lesions
Right
Left

36 (57)
27 (43)

Bronchoscopic location of the lesions
Upper right lobe
Right IMB
Middle right lobe
Lower right lobe
Upper left lobe
Lingula
Lower left lobe
Left main bronchus
Right main bronchus
Main carina

8 (12)
13 (21)
4 (6)
3 (5)
8 (13)
2 (3)
7 (11)
10 (16)
6 (10)
2 (3)

Presence and characteristics of endobronchial lesions
Exophytic mass lesions
39 (62)
Submucosal/peribronchial lesions
24 (38)

Fine needle aspiration was performed in all
patients. Out of them, 50 patients underwent biopsy,
16 patients brushing cytology, and 58 patients lavage,
and post-bronchoscopic sputum was obtained from
47 patients. Cancer was diagnosed in 48 patients by
22-gauge needle aspirations and 19-gauge needle
aspiration and 43 patients by biopsy. The sensitivity of
bronchial biopsy was 0.86. The addition of 22-gauge
and 19-gauge needle aspirations to bronchial biopsy
increased the sensitivity to 0.90 and 0.88, respectively,
but the difference was not statistically significant (P
= 1.0). Table 2 shows the procedures applied and
their results. Of the 60 patients who were diagnosed
with lung cancer through bronchoscopy, 25 (42%)
had small cell lung cancer and 35 (58%) non-small
cell lung cancer histopathologically. In 2 patients,
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Table 2. The procedures applied and their results.
Procedures

Positive n (%)

Negative n (%)

Total

Biopsy

43 (86)

7 (14)

50

19-gauge histology needle

48 (76)

15 (24)

63

22-gauge cytology needle

48 (76)

15 (24)

63

Brushing

9 (56)

7 (44)

16

Bronchoscopic lavage

33 (57)

25 (43)

58

Post-bronchoscopic sputum

21 (45)

26 (55)

47

the small-cell lung cancer diagnosis was established
based on 22-gauge needle aspiration findings due to
crush artifact in the biopsy.

endobronchial lesions. In our study the sensitivity
of a bronchial biopsy was 0.86 and the sensitivity
of transbronchial needle aspirations was 0.88. The
addition of 22-gauge and 19-gauge needle aspirations
to bronchial biopsy increased the sensitivity to 0.90.

Table 3 presents the results of biopsy and fine
needle aspirations depending on the characteristics
of the lesions. In Table 4 the results of the patients in
whom biopsy and needle aspiration were performed
are summarized, and in Table 5 the results of
19-gauge histology and 22-gauge cytology needles.
Table 6 presents the studies on the diagnostic
value of transbronchial fine needle aspiration in

The numbers of positive and negative cases with
both needles were equal (15 negative, 48 positive).
No statistically significant differences were found
between the 2 needles for positive and negative cases
(P = 1.0). The compatibility rate of the results with
both needles was 74%.

Table 3. The results of biopsy and FNA* according to the characteristics of the endobronchial lesions.
Exophytic Mass
Positive

Submucosal/Peribronchial

Negative

Positive

Negative

Biopsy

29

7

14

_

19-Gauge FNA

27

12

21

3

22-Gauge FNA

26

13

22

2

*FNA: Fine needle aspiration

Table 4. The results of the patients who underwent biopsy and FNA.*
Positive biopsy
Needle positive

Needle negative

Needle positive

Needle negative

19-Gauge FNA

36

-

-

-

22-Gauge FNA

33

-

1

-

19-Gauge+22-Gauge

31

5

1

5

*FNA: Fine needle aspiration
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Table 5. Comparisons of the FNA* results.
22-gauge cytology FNA
+
19-gauge histology FNA

Total

-

+

43

5

48

_

5

10

15

Total

48

15

63

*FNA: Fine needle aspiration

Table 6. Studies on the diagnostic value of TBFNA* in endobronchial lesions.
Studies

Biopsy positivity (%)

TBFNA positivity (%)

Biopsy plus TBFNA positivity (%)

Lundgren et al.15

69

46

_

Shure et al. 22

55

71

89

62

47

_

82

82.4

95

Dasgupta et al.

72

78

96

Kacar et al.18

72

76

96

Our study

86

88

90

16

Thida et al.

17

Govert et al.

14

*TBFNA: Transbronchial fine needle aspiration

The results with 19-gauge histology needle and
biopsy results were not statistically significantly
different (P = 0.36), and the compatibility rate of
19-gauge fine needle aspiration (FNA) and biopsy was
52%. However, the compatibility between 22-gauge
cytology needle and biopsy was 37%. The differences
between the compatibility rates of 22-gauge cytology
needle and 19-gauge histology needle with biopsy
results were not statistically significant (P = 0.43)
In 13 patients who underwent FNA only and not
biopsy, the results with both needles were positive in
11 patients. In the remaining 2 patients, the results
were positive with 22-gauge FNA only. No serious
complications developed in any of the patients during
the FNA procedure.
Discussion
Our study shows that FNA, either with 19-gauge
histology or 22-gauge cytology needle, was a useful

adjunct method in the diagnosis of lung cancer.
Although 19-gauge histology provides better
compatibility with bronchoscopic biopsy, there was
no significant difference between the 2 needles. It is
also possible to say that the use of FNA in addition
to bronchoscopic biopsy increases the yield of
bronchoscopy in the diagnosis of lung cancer.
The literature provides no data on the diagnostic
rates of these needles for endobronchial lesions.
Schenk et al. have compared the 2 needles in the
staging of lung cancer by sampling the mediastinal
lymph node (12). In their study, significant results
were obtained with 19-gauge FNA. It is reasonable
to expect better results with 19-gauge histology
needle because of its wide diameter and ability to
obtain more material; however, we could not find
a significant difference statistically. The 19-gauge
needle may be more valuable in sampling from the
lymph node but may not be so important in sampling
from endobronchial lesions.
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Fine needle aspiration significantly increases the
rate of diagnosis in endobronchial lesions (15-19).
Although endobronchial ultrasound (EBUS) (20),
computed tomography (CT) guidance (21), and rapid
on-site evaluation (ROSE) improve FNA yield (22),
these methods require considerable resources and are
not universally available. The rate of diagnosis with
FNA ranges between 65% and 92% (15-19). In our
study, diagnostic rate has been determined as 88%.
FNA may be an alternative method in the diagnosis
of endobronchial lesions, particularly in cases with a
tendency for hemorrhage, and in those with necrosis
or in those difficult to diagnose with forceps biopsy
due to crush artifact in the biopsy (23,24).
Crush artifact may occur in all pulmonary cancers.
Nevertheless, it is encountered more frequently in
small cell lung cancer (25). In our study, forceps
biopsies of 2 small cell cancer cases were negative,
while FNA results of the same cases were positive.
In endobronchial lesions, particularly submucosalperibronchial ones, the combination of TBFNA and
forceps biopsy significantly increases the diagnosis
rate (15,19). Inability to reach the lesion by forceps
biopsy and ability of the fine needle to penetrate the
tissue facilitating sampling may be important factors
in using the combined approach. Dasgupta et al.
attained a significant increase in the diagnosis rate
(from 72% to 96%) through combined application
of TBFNA with other diagnostic methods (15). In
our study, 51.3% of the lesions were submucosalperibronchial. With the addition of FNA to the
biopsy procedure, the rate of diagnosis increased to
90%.
The number of FNA procedures may increase the
sensitivity and diagnosis rate in endobronchial lesions

(18,26). Govert et al. performed FNA using a 22-gauge
cytology needle 4 times and achieved a diagnosis
rate of 95%. A larger number of FNA procedures did
not increase the risk of complications. In our study,
aspiration was performed with 2 different needles,
once with each of them. The diagnosis rate was
90%, and no serious complications were observed.
This has shown that fine needle aspiration is a safe
method and that increased number of aspirations
may increase sensitivity.
Biopsy is the method of choice because of the high
diagnostic value of the material obtained during the
diagnostic procedure of lung cancers. When multiple
biopsy samples are obtained, the rate of diagnosis
can be as high as 90% (27,28). However, in cases
with a tendency for hemorrhage and those difficult
to obtain multiple samples from, the diagnostic rates
of lesions covered with necrosis and undiagnosed
lesions because of crush artifact in the biopsy sample
increase with combined use of TBFNA. Moreover, in
submucosal-peribronchial lesions, TBFNA increases
the diagnosis rate significantly compared to forceps
biopsy (15,19).
In conclusion, transbronchial fine needle biopsy
is a safe method and it increases the diagnosis rate,
particularly in submucosal-peribronchial lesions. In
cases where sufficient material cannot be obtained
by forceps biopsy (necrosis, crush artifact), TBFNA
increases the diagnosis rate while decreasing the
need for repeated bronchoscopy. TBFNA and
biopsy combination is the optimal approach in
increasing the diagnosis rate and preventing repeated
bronchoscopy procedures. However, there was no
difference for increasing diagnostic yield in patients
with visible endobronchial lesions between 22-gauge
and 19-gauge needles.
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